查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553660

戒烟与尼古丁成瘾市场规模、份额、趋势分析报告：按类型、形式、分销管道、地区、细分市场预测，2024-2030

Smoking Cessation And Nicotine De-addiction Market Size, Share & Trends Analysis Report By Type (Nicotine Replacement Therapy), By Form, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

戒烟和脱尼古丁成瘾市场的成长和趋势：

Grand View Research, Inc.的研究报告显示，到2030年，全球戒烟和尼古丁成瘾市场规模预计将达到509亿美元，2024年至2030年复合年增长率为10.4%。

世界各地吸烟成瘾的人数正在迅速增加。此族群主要包括青少年和劳动人口。吸烟造成的死亡率非常高。日益增长的戒烟愿望以及与吸烟相关的许多健康併发症是公司推出创新戒烟产品的强大动力，例如Revolmar，该公司推出了下一代尼古丁口香糖来帮助吸烟者戒烟。这种改进和创新的尼古丁替代疗法产品的推出将成为戒烟和尼古丁成瘾市场成长的有力推动力。

慢性阻塞性肺病（COPD）、气喘、心臟疾病和肺癌等目标疾病的盛行率不断上升，以及对吸烟有害副作用的认识不断提高，预计将推动市场扩张。教育机构正在积极开展各种宣传活动和方案，传播有关吸烟有害影响和后果的讯息，提高年轻人的认识。

戒烟和脱尼古丁成瘾市场报告亮点

  • 尼古丁替代疗法（NRT）在 2023 年的戒烟和去尼古丁成瘾产品市场中占据主导地位。常用的NRT产品包括尼古丁口香糖和经皮吸收贴片。可用性的增加和各种口味的可摄取尼古丁产品的推出是获得巨大市场占有率的因素。
  • 预计电子烟产业在预测期内将以 8.48% 的复合年增长率成长。电子烟市场成长的主要因素是第二代和第三代电子烟的推出、各种口味产品的供应、众多以不同品牌经营和销售电子烟的供应商的存在等。
  • 2023年，北美占据成瘾和尼古丁戒断市场占有率的40.3%。
  • 亚太地区是成长最快的地区。尼古丁戒烟产品和电子烟在中国、印度和澳洲等国家的註册以及企业分销管道的加强将支持预测期内的成长。
  • 市场参与者透过专注于 FDA核准的尼古丁产品的市场开拓、商业化和分销，在电子烟市场取得缓慢但稳定的进展。例如，胜利电子烟公司于2014年收购了十动机有限公司，旨在扩大销售管道并获得更广泛的市场覆盖范围。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 戒烟和戒除尼古丁成瘾的市场变数、趋势和范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 戒烟与脱尼古丁成瘾市场分析工具
    • 波特的分析
    • PESTEL分析
    • 政局
    • 经济和社会状况
    • 技术景观
    • 环境状况
    • 法律状况

第 4 章：戒烟和戒除尼古丁成瘾市场：按类型估计和趋势分析

  • 细分仪表板
  • 尼古丁替代疗法
  • 药物治疗
  • 电子烟

第五章戒烟和戒除尼古丁成瘾市场：按表格类型的估计和趋势分析

  • 细分仪表板
  • 戒烟与脱尼古丁成瘾市场：2023 年和 2030 年按形式类型变化分析
  • 胶
  • 吸入器
  • 药片
  • 其他的

第六章戒烟和尼古丁戒断成瘾：按分销管道类型进行估计和趋势分析

  • 细分仪表板
  • 戒烟与脱尼古丁成瘾市场：2023 年和 2030 年按通路类型分類的波动分析
  • 医院药房
  • 在线的
  • 药局和药房

第七章吸烟吸烟和脱尼古丁成瘾市场：区域估计和趋势分析

  • 2023 年和 2030 年戒烟和脱尼古丁成瘾市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Rusan Pharma Ltd
    • Dr. Reddy's Laboratories Ltd
    • Imperial Brands Plc
    • Zydus Group.
    • British American Tobacco Plc
    • Perrigo Company Plc
    • Johnson and Johnson Inc
    • NJOY, LLC
    • Cipla Ltd
    • GlaxoSmithKline Plc.
简介目录
Product Code: 978-1-68038-908-1

Smoking Cessation And Nicotine De-addiction Market Growth & Trends:

The global smoking cessation and nicotine de-addiction market size is expected to reach USD 50.90 billion by 2030, growing at a CAGR of 10.4% from 2024 to 2030, according to a report by Grand View Research, Inc. The base of population addicted to smoking is rapidly increasing across the globe. This population subset majorly includes teenagers and the working population. Smoking-related mortality is very high. The increasing desire to quit smoking and the numerous health complications associated with smoking serve as strong incentives for companies to introduce novel smoking cessation products, such as Revolymer, which has introduced the next generation nicotine gums to help smokers quit smoking. The launch of these improved and innovative nicotine replacement therapy products is to serve as a high impact rendering driver for the growth of the smoking cessation and nicotine de-addiction market.

The growing incidence of target diseases such as chronic obstructive pulmonary disease (COPD), asthma, cardiac diseases, and lung cancer, and the increasing awareness pertaining to the hazardous side-effects of smoking are the factors expected to promote market expansion. Educational institutions remain active in organizing various campaigns and programs to spread information about the harmful effects and consequences of smoking so as to increase young population awareness.

Smoking Cessation And Nicotine De-addiction Market Report Highlights:

  • Nicotine Replacement Therapy (NRT) dominated the smoking cessation and de-nicotine addiction product market in 2023. Majorly used NRT products include nicotine chewing gums and the transdermal patches. Increased availability and the introduction of the ingestible nicotine products with different flavors are the factors responsible for its large market share.
  • The e-cigarette segment is anticipated to grow at a CAGR of 8.48% over the forecast period. The major factors responsible for the growth of the E-cigarette market include the introduction of second and third generation e-cigarettes, the availability of various flavored products, the presence of numerous vendors operating and selling e-cigarettes under different brand names.
  • North America dominated the smoking cessation and nicotine de-addiction market with a market share of 40.3% in 2023.
  • Asia Pacific is the fastest growing market. The registration of nicotine de-addiction products and e-cigarettes as well as the strengthening of the company distribution channels in countries, such as China, India, and Australia are expected to support the growth over the forecast period.
  • The market players are making slow but steady progress in the e-cigarette market by focusing on the development, commercialization, and distribution of the FDA approved nicotine products. For instance, in 2014, Victory Electronic Cigarettes Corporation acquired Ten Motives Ltd. with an aim to expand their distribution channels and attain wider market coverage.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Smoking Cessation and Nicotine De-addiction Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Smoking Cessation and Nicotine De-addiction Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1 Bargaining power of the suppliers
      • 3.4.1.2 Bargaining power of the buyers
      • 3.4.1.3 Threats of substitution
      • 3.4.1.4 Threats from new entrants
      • 3.4.1.5 Competitive rivalry
    • 3.4.2. PESTEL Analysis
    • 3.4.3 Political landscape
    • 3.4.4 Economic and Social landscape
    • 3.4.5 Technological landscape
    • 3.4.6 Environmental landscape
    • 3.4.7 Legal landscape

Chapter 4. Smoking Cessation and Nicotine De-addiction Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Nicotine Replacement Therapy
    • 4.2.1. Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2 Nicotine Lozenges
      • 4.2.2.1 Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3 Nicotine Gums
      • 4.2.3.1 Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.4 Nicotine Sprays
      • 4.2.4.1 Nicotine Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.5 Nicotine Inhalers
  • 4.3. Drug Therapy
    • 4.3.1. Drug Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. E-cigarettes
    • 4.4.1. E-cigarettes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Smoking Cessation and Nicotine De-addiction Market: Form Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Smoking Cessation and Nicotine De-addiction Market: Form Type Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Gum
    • 5.3.1. Gum Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Inhalers
    • 5.4.1. Inhalers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Tablets
    • 5.5.1. Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Smoking Cessation and Nicotine De-addiction Market: Distribution Channel Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Smoking Cessation and Nicotine De-addiction Market: Distribution Channel Type Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Online
    • 6.4.1. Online Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Drug stores and Retail Pharmacies
    • 6.5.1. Drug stores and Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Smoking Cessation and Nicotine De-addiction Market : Regional Estimates & Trend Analysis

  • 7.1. Smoking Cessation and Nicotine De-addiction Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1 U.S. Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1 Canada Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1 Mexico Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1 UK Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1 Germany Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1 France Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1 Italy Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1 Spain Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1 Denmark Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1 Sweden Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1 Norway Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1 Japan Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1 China Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1 India Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1 Australia Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1 South Korea Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1 Thailand Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1 Brazil Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1 Argentina Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1 South Africa Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1 Saudi Arabia Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1 UAE Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1 Kuwait Smoking Cessation and Nicotine De-addiction Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Rusan Pharma Ltd
      • 8.4.1.1 Participant's Overview
      • 8.4.1.2 Financial Performance
      • 8.4.1.3 Product Benchmarking
      • 8.4.1.4 Recent Developments/ Strategic Initiatives
    • 8.4.2. Dr. Reddy's Laboratories Ltd
      • 8.4.2.1 Participant's Overview
      • 8.4.2.2 Financial Performance
      • 8.4.2.3 Product Benchmarking
      • 8.4.2.4 Recent Developments/ Strategic Initiatives
    • 8.4.3. Imperial Brands Plc
      • 8.4.3.1 Participant's Overview
      • 8.4.3.2 Financial Performance
      • 8.4.3.3 Product Benchmarking
      • 8.4.3.4 Recent Developments/ Strategic Initiatives
    • 8.4.4. Zydus Group.
      • 8.4.4.1 Participant's Overview
      • 8.4.4.2 Financial Performance
      • 8.4.4.3 Product Benchmarking
      • 8.4.4.4 Recent Developments/ Strategic Initiatives
    • 8.4.5. British American Tobacco Plc
      • 8.4.5.1 Participant's Overview
      • 8.4.5.2 Financial Performance
      • 8.4.5.3 Product Benchmarking
      • 8.4.5.4 Recent Developments/ Strategic Initiatives
    • 8.4.6. Perrigo Company Plc
      • 8.4.6.1 Participant's Overview
      • 8.4.6.2 Financial Performance
      • 8.4.6.3 Product Benchmarking
      • 8.4.6.4 Recent Developments/ Strategic Initiatives
    • 8.4.7. Johnson and Johnson Inc
      • 8.4.7.1 Participant's Overview
      • 8.4.7.2 Financial Performance
      • 8.4.7.3 Product Benchmarking
      • 8.4.7.4 Recent Developments/ Strategic Initiatives
    • 8.4.8. NJOY, LLC
      • 8.4.8.1 Participant's Overview
      • 8.4.8.2 Financial Performance
      • 8.4.8.3 Product Benchmarking
      • 8.4.8.4 Recent Developments/ Strategic Initiatives
    • 8.4.9. Cipla Ltd
      • 8.4.9.1 Participant's Overview
      • 8.4.9.2 Financial Performance
      • 8.4.9.3 Product Benchmarking
      • 8.4.9.4 Recent Developments/ Strategic Initiatives
    • 8.4.10. GlaxoSmithKline Plc.
      • 8.4.10.1 Participant's Overview
      • 8.4.10.2 Financial Performance
      • 8.4.10.3 Product Benchmarking
      • 8.4.10.4 Recent Developments/ Strategic Initiatives